Positions

Selected Publications

Academic Article

Year Title Altmetric
2020 Risk of subsequent malignant neoplasms after an index potentially-human papillomavirus (HPV)-associated cancers 2020
2020 The Reliability of Intraoperative Assessment on Predicting Tumor Size, Myometrial Invasion, and Cervical Involvement in Patients with a Preoperative Diagnosis of Complex Atypical Hyperplasia or (Clinical Stage I) Endometrial Cancer: A Prospective Cohort Study 2020
2020 A batch-effect adjusted Simon's two-stage design for cancer vaccine clinical studiesBiometrics2020
2018 Access to gynecologic oncology care and the network adequacy standardCancer.  124:2677-2679. 2018
2018 Lessons learned from domestic and international human papillomavirus vaccination programs: a reviewAmerican Journal of Obstetrics and Gynecology.  218:467-473. 2018
2017 Transitioning from HPV 101 to HPV 202American Journal of Obstetrics and Gynecology.  216:206-207. 2017
2016 Expression of p16INK4A in cervical precancerous lesions is unlikely to be preventable by human papillomavirus vaccinesCancer.  122:3615-3623. 2016
2016 Cervical cancer screening: Evidence behind the guidelinesAmerican Journal of Obstetrics and Gynecology.  214:438-443. 2016
2016 ReplyAmerican Journal of Obstetrics and Gynecology.  214:296-297. 2016
2015 Obesity and perioperative pulmonary complications in robotic gynecologic surgeryAmerican Journal of Obstetrics and Gynecology.  213:33.e1-33.e7. 2015
2015 Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer ScreeningApplied Health Economics and Health Policy.  13:95-107. 2015
2014 Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: Analysis of women in the control arm of the randomized, controlled PATRICIA trialBMC Infectious Diseases.  14. 2014
2013 Human papillomavirus: What every provider should knowAmerican Journal of Obstetrics and Gynecology.  208:169-175. 2013
2012 Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: Retrospective pooled analysis of trial dataBMJ.  344. 2012
2009 Introduction: Human Papillomavirus-A Clear, Present, and Common DangerAmerican Journal of Medicine.  122. 2009
2004 Optical detection of high-grade cervical intraepithelial neoplasia in vivo: Results of a 604-patient studyAmerican Journal of Obstetrics and Gynecology.  190:1249-1257. 2004
2003 Human Papillomavirus Triage of Patients with Atypical Squamous Cells of Undetermined Significance on Cervical Papanicolaou SmearAnnals of the Academy of Medicine, Singapore.  32:590-596. 2003

Chapter

Year Title Altmetric
2018 Cervical cancer.  165-172. 2018
2018 Radical hysterectomy.  2136-2145. 2018
2014 A 38-year-old woman with heavy vaginal bleeding 6 months after D & C for complete mole.  282-284. 2014
2014 A 62-year-old woman with a vulvar lesion.  285-286. 2014
2014 A 64-year-old woman with ovarian cancer, emesis, and abdominal pain.  290-293. 2014
2014 A 65-year-old woman with new-onset fatigue, parasthesias, and muscle cramps after chemotherapy for ovarian cancer.  294-296. 2014
2013 Preinvasive disease of the lower genital tract.  129-150. 2013
2007 Prognostic markers of uterine papillary serous carcinoma.  217-224. 2007

Principal Investigator On

  • Addressing Emerging Health System Priorities in Cervical Cancer Prevention  awarded by University of British Columbia 2018 - 2023
  • UAB 1753 A Randomized Placebo Controlled Phase II Trial of Metformin in Conjunction with Chemotherapy Followed by Metformin Maintenance Therapy in Advanced Stage Ovarian, Fallopian Tube and Primary Peritoneal Cancer  awarded by University of Chicago ^ 2018 - 2023
  • NLOCF Drive Out Ovarian Cancer Research Award  awarded by NORMA LIVINGSTON OVARIAN CANCER FOUNDATION 2017 - 2021
  • UAB Referral Colposcopy Clinic  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2020 - 2021
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2018 - 2021
  • SPORE in Cervical Cancer  awarded by Johns Hopkins University 2019 - 2021
  • SPORE in Cervical Cancer - Core A: Administrative Core  awarded by Johns Hopkins University 2019 - 2021
  • SPORE in Cervical Cancer - Project 1: Heat Stable RG1-VLPs, A Candidate Broadly Protective Vaccine for the Prevention of HPV-Associated Cancer  awarded by Johns Hopkins University 2019 - 2021
  • SPORE in Cervical Cancer - Project 2: DNA Prime-protein Boost Vaccination to treat HPV16 Infection in Women with ASC-US or LSIL  awarded by Johns Hopkins University 2019 - 2021
  • SPORE in Cervical Cancer - Project 3: Electroporation Delivery of pNGVL4aCRTE6E7L2 DNA for treatment of HPV16+ CIN2/3 Patients  awarded by Johns Hopkins University 2019 - 2021
  • Therapeutic Use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial  awarded by Hutchinson (Fred) Cancer Research Center 2020 - 2021
  • UAB Referral Colposcopy Clinic  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2019 - 2020
  • UAB Referral Colposcopy  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2018 - 2019
  • SPORE in Cervical Cancer  awarded by Johns Hopkins University 2014 - 2019
  • SPORE in Cervical Cancer - Administrative Core  awarded by Johns Hopkins University 2014 - 2019
  • SPORE in Cervical Cancer - Developmental Research Program  awarded by Johns Hopkins University 2014 - 2019
  • SPORE in Cervical Cancer - Pilot Project: An Assessment of Immunogenicity in Adolescent Women receiving Gardasil, Gardasil 9, or Cervarix  awarded by Johns Hopkins University 2014 - 2019
  • SPORE in Cervical Cancer - Project 1  awarded by Johns Hopkins University 2014 - 2019
  • SPORE in Cervical Cancer - Project 2  awarded by Johns Hopkins University 2014 - 2019
  • SPORE in Cervical Cancer - Project 3  awarded by Johns Hopkins University 2014 - 2019
  • UAB NRG Oncology Member Institution Purchased Service Agreement  awarded by NRG ONCOLOGY FOUNDATION 2014 - 2019
  • UAB Referral Colposcopy Clinic  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2017 - 2018
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2014 - 2018
  • Woman to Woman Program: Volunteer Mentoring Program for Newly Diagnosed Ovarian Cancer Patients  awarded by Ovarian Cancer Research Fund, Inc. 2015 - 2018
  • UAB Referral Colposcopy Clinic  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2016 - 2017
  • Comprehensive Cancer Center Core Support Grant - Prevalence and Genotype Distribution of Cervical and Oral HPV Infection in HIV+Brazilian Women  awarded by National Cancer Institute/NIH/DHHS 2016 - 2017
  • Private Grant  awarded by ADVAXIS, INC. 2016 - 2017
  • UAB Referral Colposcopy Clinic  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2016
  • Private Grant  awarded by AMGEN, INC.^ 2012 - 2016
  • Gynecologic Oncology Group Clinical Trials  awarded by GYNECOLOGIC ONCOLOGY GROUP 2012 - 2016
  • UAB Referral Colposcopy Clinic  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2014 - 2015
  • UAB Referral Colposcopy Clinic  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2013 - 2014
  • SPORE in Cervical Cancer - Project 1  awarded by Johns Hopkins University 2009 - 2014
  • SPORE in Cervical Cancer - Project 2  awarded by Johns Hopkins University 2009 - 2014
  • A Phase I Study to Evaluate the Safety and Immunogenicity of HPV 16 L2 11-200  awarded by National Cancer Institute/NIH/DHHS 2008 - 2014
  • Development of an HPV Vaccine for Global Prevention of Cervical Neoplasia  awarded by American Cancer Society, Inc. 2008 - 2014
  • Private Grant  awarded by INTUITIVE SURGICAL 2012 - 2014
  • UAB Referral Colposcopy Clinic  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2012 - 2013
  • UAB Referral Colposcopy Clinic  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2011 - 2012
  • Private Grant  awarded by MERCK & COMPANY, INC. ^ 2008 - 2011
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC. 2004 - 2011
  • UAB Referral Colposcopy Clinic  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2010 - 2011
  • Private Grant  awarded by GlaxoSmithKline 2004 - 2010
  • UAB Referral Colposcopy Clinic  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2009 - 2010
  • Private Grant  awarded by MGI PHARMA, INC. 2005 - 2009
  • Investigator On

  • Private Grant  awarded by Leap Therapeutics, Inc. 2021 - 2026
  • Private Grant  awarded by SEAGEN INC 2021 - 2026
  • UAB 18107 - A Phase 2, Single Arm Study of Atezolizumab + Bevacizumab in Women with Advanced, Recurrent or Persistent Endometrial Cancer  awarded by University of Oklahoma 2020 - 2025
  • Private Grant  awarded by RUBIUS THERAPEUTICS INC 2021 - 2025
  • Private Grant  awarded by TESARO, INC. 2019 - 2024
  • ECOG-ACRIN Purchase Service Agreement  awarded by Eastern Cooperative Oncology Group 2019 - 2024
  • NRG Oncology Member Institution Clinical Trial Fixed Price Subaward Agreement  awarded by NRG ONCOLOGY FOUNDATION 2019 - 2024
  • Private Grant  awarded by CELSION CORPORATION 2018 - 2023
  • Private Grant  awarded by GENMAB 2018 - 2023
  • Private Grant  awarded by AGENUS, INC. 2020 - 2023
  • Private Grant  awarded by Leap Therapeutics, Inc. 2017 - 2022
  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP 2015 - 2022
  • UAB 1788: Pilot Study of Daily Exemestane in Women with Complex Alypical Hyperplasia of The Endometrium / Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer (Fixed Price)  awarded by University of Wisconsin-Madison 2017 - 2021
  • UAB 1788; Pilot Study of Daily Exemestane in Women with Complex Alypical Hyperplasia of The Endometrium / Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer (Cost Reimbursable)  awarded by University of Wisconsin-Madison 2017 - 2021
  • Private Grant  awarded by ABBVIE INC 2015 - 2021
  • Private Grant  awarded by TESARO, INC. 2016 - 2021
  • Neoadjuvant Chemotherapy Tumor Profiling in Ovarian Cancer: Genomic and Proteomic Analysis  awarded by NRG ONCOLOGY FOUNDATION 2016 - 2021
  • Private Grant  awarded by MATEON THERAPEUTICS, INC. 2016 - 2021
  • UAB 1764:The Targeted Agent and Profiling Utilization Registry (TAPUR) Study  awarded by American Society of Clinical Oncology 2017 - 2021
  • Discovery and Evaluation of Tests for Endometrial Cancer using Tampons Evaluation of Molecular Markers in Vaginal Tampon Samples for Early Detection of Endometrial Cancer in Diverse Populations  awarded by NIH - National Institutes of Health/DHHS 2020 - 2021
  • SPORE in Cervical Cancer - Career Enhancement Program  awarded by Johns Hopkins University 2019 - 2021
  • Private Grant  awarded by CELSION CORPORATION 2015 - 2021
  • Cervical Cancer Derived Xenografts (PDX) and Organoid Raft Cultures to Evaluate Pathway Specific Therapeutic Agents.  awarded by National Cancer Institute/NIH/DHHS 2019 - 2021
  • Private Grant  awarded by PLEXXIKON 2016 - 2021
  • Private Grant  awarded by TAPIMMUNE, INC. 2018 - 2020
  • ECOG-ACRIN Purchase Service Agreement  awarded by Eastern Cooperative Oncology Group 2014 - 2020
  • Private Grant  awarded by IMMUNOGEN, INC. 2017 - 2019
  • Private Grant  awarded by DECIPHERA PHARMACEUTICALS. LLC 2018 - 2019
  • Implementation of Direct-to-Patient Telemedicine Healthcare Initiatives  awarded by UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION 2017 - 2019
  • Private Grant  awarded by MILLENNIUM PHARMACEUTICALS, INC. 2018 - 2019
  • CITY Health II - The Center for the Study of Community Health  awarded by National Center for Chronic Disease Prevention & Health Promo./CDC/DHHS 2014 - 2019
  • COMPLETED - SPORE in Cervical Cancer - Project 4  awarded by Johns Hopkins University 2014 - 2019
  • UAB NRG Oncology Master Institution Purchased Service Agreement  awarded by NRG ONCOLOGY FOUNDATION 2019
  • Private Grant  awarded by SYNDAX PHARMACEUTICALS 2017 - 2019
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS 2017 - 2019
  • Private Grant  awarded by Genentech 2017 - 2019
  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP 2018 - 2019
  • NCTN Deep South Research Consortium  awarded by National Cancer Institute/NIH/DHHS 2018 - 2019
  • UAB NRG Oncology Member Institution Purchased Service Agreement  awarded by NRG ONCOLOGY FOUNDATION 2015 - 2019
  • Private Grant  awarded by LICOR, INC. 2017 - 2019
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2014 - 2018
  • NCTN Deep South Research Consortium  awarded by National Cancer Institute/NIH/DHHS 2016 - 2018
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS 2016 - 2017
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2016
  • Private Grant  awarded by ONCOTHYREON, INC. 2015 - 2016
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2016
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS 2011 - 2016
  • NCTN Deep South Research Consortium  awarded by National Cancer Institute/NIH/DHHS 2014 - 2016
  • Private Grant  awarded by Pfizer Pharmaceuticals 2012 - 2015
  • Private Grant  awarded by ASTRAZENECA AB 2014 - 2015
  • Private Grant  awarded by LEIDOS BIOMEDICAL RESEARCH, INC. 2013 - 2014
  • SPORE in Cervical Cancer  awarded by Johns Hopkins University 2009 - 2014
  • SPORE in Cervical Cancer - Project 4  awarded by Johns Hopkins University 2009 - 2014
  • Tissue Resource Site (TSS) in Support of the The Cancer Genome Atlas (TCGA) Program - Admin Core  awarded by SAIC - FREDERICK 2013 - 2014
  • Private Grant  awarded by MERRIMACK PHARMACEUTICALS, INC. 2012 - 2014
  • A Randomized Phase III Trial of Every-3-Weeks Paclitaxel Versus Dose Dense Weekly Paclitaxel in Combination with Carboplatin With or Without Concurrent and Consolidation Bevacizumab (NSC #704865, IND #7921) in the Treatment of Primary Stage III or IV Epithelial Ovarian, Peritoneal or Fallopian Tube Cancer  awarded by American College of Radiology Imaging Network 2012 - 2014
  • Predictors of Survival Outcomes for Carcinosarcoma of the Female Genital Tract  awarded by University of Minnesota 2013
  • ACRIN 6682: Phase II Trial of 64 CU-ATSM PET/CT in Cervical Cancer (R09-186)  awarded by American College of Radiology 2010 - 2013
  • Private Grant  awarded by MORPHOTEK, INC. 2010 - 2013
  • Private Grant  awarded by MORPHOTEK, INC. 2011 - 2013
  • Private Grant  awarded by Genentech 2011 - 2013
  • Private Grant  awarded by TRACON PHARMACEUTICALS, INC. 2011 - 2012
  • Zambian Cervical Cancer Research Capacity Initiative  awarded by National Cancer Institute/NIH/DHHS 2011 - 2012
  • Private Grant  awarded by DAIICHI SANKYO PHARMA DEVELOPMENT 2011 - 2012
  • Education And Training

  • Doctor of Medicine, Georgetown University 1995
  • New England Medical Center, Internship 1996
  • New England Medical Center, Residency 1999
  • UAB Hospital, Postdoctoral Fellowship 2002
  • Full Name

  • Warner Huh